Oracle shares turn lower as quarterly revenue miss overshadows cloud deals

Shares of AstraZeneca (NASDAQ: AZN) surged over 10% this week following positive clinical results for Enhertu in HER2-positive breast cancer and a significant deal between Pfizer (NYSE: PFE) and the Trump administration, where Pfizer will reduce drug prices and invest $70 billion domestically, gaining a three-year exemption from tariffs on pharmaceutical imports. This agreement was highlighted during a press conference with Pfizer CEO Albert Bourla and President Trump. Want More Context? 🔎

Shares of Carnival (NYSE: CCL) dipped despite a strong Q3 earnings report, with revenue rising 3.3% to $8.15 billion and adjusted net income improving to $1.98 billion, surpassing estimates. The company raised its guidance for the year, projecting a 55% increase in adjusted net income to $2.95 billion and a 15% rise in adjusted EBITDA to $7.05 billion, driven by higher net yields and cost management. Want More Context? 🔎

Opendoor Technologies (NASDAQ: OPEN) operates in the iBuying sector, purchasing and selling homes, and could benefit from declining interest rates amid economic challenges. However, investors should be wary of the company's low gross margins, which pose significant risks independent of the housing market's performance. Want More Context? 🔎

Reddit (NYSE: RDDT) has become one of the world's most visited websites, leveraging its focused subreddits for targeted advertising without cookie tracking, leading to significant monetization and growth. With a staggering 260% stock increase over the past year, Reddit's market cap has reached $45 billion, raising questions about whether it's still a viable growth investment. Want More Context? 🔎

Shares of Datadog (NASDAQ: DDOG) increased by 7.2% following an overweight rating and $190 price target set by Wells Fargo analysts. They emphasized Datadog's potential as a key player in the growing demand for AI tools, noting its unified platform that enhances monitoring and security across cloud environments. Want More Context? 🔎

Pfizer (NYSE: PFE) has signed an agreement with the White House to help Americans access lower prescription drug prices and enhance U.S. biopharmaceutical innovation through a new website, "TrumpRx," which connects patients to discounted drugs. President Trump and Pfizer CEO Albert Bourla emphasized the importance of this deal in addressing the financial burdens on American consumers who fund global research and development. Want More Context? 🔎